GSKvsUnitedHealth

GSK and UNH stock compared: price, dividend, valuation and results, from SEC filings.

UNH

UnitedHealth Group Incorporated

$339.85

Value $308B

+2.84%
UNH's page

GSK (GSK) has a market value of $96.7B and UnitedHealth (UNH) $308B. Over the last year, with dividends, GSK moved +6.8% and UNH +12.9%. The P/E is 12.6 for GSK and 19.4 for UNH. Dividend yield: GSK 3.72%, UNH 2.67%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    GSK$96.7B

    UNH$308B

    UNH is 3.2 times GSK

  • Revenue, 12 months

    GSK$43.9B

    UNH$450B

    UNH is 10 times GSK

  • Net income, 12 months

    GSK$7.7B

    UNH$15.9B

    UNH is 2.1 times GSK

  • Operating margin

    GSK24.3%

    UNH5.3%

    19.0 points apart

  • ROIC

    GSK18.6%

    UNH11.3%

    7.3 points apart

  • P/E

    GSK12.6

    UNH19.4

    UNH is 1.5 times GSK

  • Dividend yield

    GSK3.7%

    UNH2.7%

    1.0 points apart

  • 5-year return

    GSK+40.2%

    UNH-15.4%

    55.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

GSK+40.2%

UNH-15.4%

10015020222023202420252026
Returns by period
PeriodGSKWith dividendsUNHWith dividends
1 year since November 19, 2025+6.8%Price +3.1%+12.9%Price +10.0%
3 years since November 20, 2023+52.8%+15.2% a yearPrice +36.0%-32.4%-12.2% a yearPrice -36.5%
5 years since November 19, 2021+40.2%+7.0% a yearPrice +14.8%-15.4%-3.3% a yearPrice -22.8%
10 years since November 21, 2016+97.4%+7.0% a yearPrice +24.3%+166.8%+10.3% a yearPrice +125.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

GSKGSKUNHUnitedHealth

Valuation

GSKUNH
Valuation
Price$47.76$339.85
Market value$96.7B$308B
Enterprise value (EV)$117B$354B
P/E12.619.4
P/E, 5-year median13.125.0
P/B4.53.0
EV/EBIT11.014.8
Free cash flow yield8.9%7.4%

Results and growth

GSKUNH
Results and growth
Revenue, 12 months$43.9B$450B
Net income, 12 months$7.7B$15.9B
Free cash flow, 12 months$8.6B$22.8B
Earnings per share, 12 months$3.73$17.52
Revenue growth, year on year4.1%11.8%
Revenue growth a year, past+6.1%over 5 years+11.7%over 5 years
EPS growth a year, past-0.5%over 5 years-3.8%over 5 years

Margins and returns on capital

GSKUNH
Margins and returns on capital
Gross margin72.4%88.3%
Operating margin24.3%5.3%
Net margin17.5%3.5%
ROIC18.6%11.3%
ROE35.8%15.5%

Balance sheet

GSKUNH
Balance sheet
Cash$4.6B$28.5B
Total debt$24.9B$74.3B
Net debt / EBITDA1.51.6
Interest cover–6.2×

Dividends and buybacks

GSKUNH
Dividends and buybacks
Dividend yield3.7%2.7%
Dividend per share, 12 months$1.78$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield1.9%1.8%
Shareholder yield5.6%4.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: GSK or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, GSK or UnitedHealth?

By market value, UnitedHealth ($308B) is about 3.2 times GSK ($96.7B), at today's prices.

How did GSK and UNH stock do over the last 10 years?

Since November 21, 2016, GSK's price moved +24.3% and UNH's +125.9%. With dividends: GSK +97.4% (+7.0% a year), UNH +166.8% (+10.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, GSK or UNH?

The dividend yield at today's price is 3.72% for GSK and 2.67% for UnitedHealth. Over the last twelve months they paid $1.78 and $9.06 per share.

What is the P/E of GSK and UNH?

At today's price, the P/E is 12.6 for GSK and 19.4 for UNH. The median of the last five years was 13.1 and 25.0, which shows where each stands against its own past.

Which has the higher profit margins, GSK or UnitedHealth?

Over the last twelve months, the net margin was 17.5% for GSK and 3.5% for UnitedHealth, and the operating margin 24.3% and 5.3%. Revenue was $43.9B and $450B.

Which is the better investment, GSK or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.